ANI PHARMACEUTICALS, INC Accrued Income Taxes, Current
ANI PHARMACEUTICALS, INC (ANIP) had Accrued Income Taxes, Current of $0 as of 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2022-03-15
- 2021-12-31: Accrued Income Taxes, Current $0.00.
- 2021-03-31: Accrued Income Taxes, Current $3.66M.
- 2020-12-31: Accrued Income Taxes, Current $3.91M.
- 2020-06-30: Accrued Income Taxes, Current $8.29M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-15 |
| 2021-03-31 | $3.66M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $3.91M 10-K · filed 2022-03-15 |
| 2020-06-30 | $8.29M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $15.22M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-11 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-06 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-07 |
| 2019-03-31 | $3.45M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.02M 10-K · filed 2020-02-27 |
| 2018-09-30 | $318.00K 10-Q · filed 2018-11-06 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-27 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 |
| 2017-03-31 | $3.66M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $2.40M 10-K · filed 2018-02-27 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-02 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-03 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-04 |
| 2015-03-31 | $481.00K 10-Q · filed 2015-05-05 |
| 2014-12-31 | $4.25M 10-K · filed 2016-02-23 |
| 2013-12-31 | $20.00K 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |